Multiple basal cell carcinomas associated with hairy cell leukaemia

British Journal of Dermatology

Volumn 140, Issue 1, 1999, Pages 150-153

  Schon M P ^a   Reifenberger, J ^a   Von Schmiedeberg, S ^a   Megahed, M ^a   Lang, K ^a   Gattermann, N ^a   Meckenstock, G ^a   Goerz, G ^a   Ruzicka, T ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Basal cell carcinoma; Hairy cell leukaemia; Sun exposure; T cell immune dysregulation

Indexed keywords

ARTICLE; BASAL CELL CARCINOMA; CARCINOGENESIS; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HAIRY CELL LEUKEMIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; PRIORITY JOURNAL; SKIN BIOPSY;

CARCINOMA, BASAL CELL; FEMALE; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, HAIRY CELL; MIDDLE AGED; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 0032977181     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02626.x     Document Type: Article

References (26)

1. Sober AJ. Diagnosis and management of skin cancer. Cancer 1983; 51: 2448-52.
2. Moll R, Franke WW, Vole-Platzer B, Krepler R. Different keratin polypeptides in epidermis and other epithelia of human skin: A specific cytokeratin of molecular weight 46,000 in epithelia of the pilosebaceous tract and basal cell epitheliomas. J Cell Biol 1982; 95: 285-95.
3. Pollack SV, Goslen JB, Sherertz EF, Jegasothy BV. The biology of basal cell carcinoma: A review. J Am Acad Dermatol 1982; 7: 569-77.
4. Klein CE, Hartmann B, Schön MP, et al. Expression of a 38-kD cell-surface glycoprotein in transformed human keratinocyte cell lines, basal cell carcinomas, and epithelial germs. J Invest Dermatol 1990; 95: 74-82.
5. Carter DM, Lin AN. Basal cell carcinoma. In: Dermatology in General Medicine (Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds), 4th edn. New York: McGraw-Hill, 1993; 840-7.
6. Clendenning WE, Block JB, Radde JG. Basal cell nevus syndrome. Arch Dermatol 1964; 90: 38-53.
7. Cleaver JE, Bootsma D. Xeroderma pigmentosum: Biochemical and genetic characteristics. Annu Rev Genet 1975; 9: 19-38.
8. Hahn H, Wicking C, Zaphiropoulos PG et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996; 85: 841-51.
9. Gailani MR, Stahle-Bäckdahl M, Leffell DJ, et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 1996; 14: 78-81.
10. Wolter M, Reifenberger J, Sommer C, et al. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1997; 57: 2581-5.
11. Lear JT, Heagerty AHM, Smith A et al. Multiple cutaneous basal cell carcinomas: Glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumor numbers and accrual. Carcinogenesis 1996; 17: 1891-6.
12. Turner A, Kjeldsberg CR. Hairy cell leukemia: A review. Medicine 1978; 57: 477-99.
13. Dalal BL, Fitzpatrick DA. Hairy cell leukemia: An update. Lab Med 1991; 22: 31-40.
14. Kluin-Nelemans JC, Kester MGD, Melenhorst JJ et al. Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood 1996; 87: 3795-802.
15. Möller P, Mielke B, Moldenhauer G. Monoclonal antibody HML-1, a marker for intraepithelial T-cells and lymphomas thereof, also recognizes hairy cell leukemia and some B-cell lymphomas. Am J Pathol 1990; 136: 509-12.
16. Hersh EM, Murphy S, Zander A et al. Host defense deficiency in hairy cell leukemia and its correction by leukocyte transfusion. Blood 1980; 56: 526-32.
17. McInnes S, Golomb HM. Infectious complications in hairy cell leukemia. Contemp Oncol 1994; 4: 14-18.
18. Jacobs RH, Vokes EE, Golomb HM. Second malignancies in hairy cell leukemia. Cancer 1985; 56: 1462-7.
19. Nielsen B, Braide I, Hasselbach H. Evidence for an association between hairy cell leukemia and renal cell and colorectal carcinoma. Cancer 1992; 70: 2087-90.
20. Lebbe C, Rybojad M, Ochonisky S et al. Extensive human papillomavirus-related disease (bowenoid papulosis, Bowen's disease, and squamous cell carcinoma) in a patient with hairy cell leukemia: Clinical and immunologic evaluation after an interferon alfa trial. J Am Acad Dermatol 1993; 29: 644-6.
21. Kraut EH, Grever MR, Bouroncle BA. Long-term follow-up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin. Blood 1994; 84: 4061-3.
22. Kampmeier P, Spielberger R, Dickstein J et al. Increased incidence of second neoplasms in patients treated with interferon α 2b for hairy cell leukemia: A clinicopathologic assessment. Blood 1994; 83: 2931-8.
23. Walder BK, Robertson MR, Jeremy D. Skin cancer and immunosuppression. Lancet 1971; ii: 1282-3.
24. Kurwa HA, Marks R. Protracted cutaneous disorders in association with low CD4+ lymphocyte counts. Br J Dermatol 1995; 133: 625-9.
25. Hardman CM, Baker BS, Lortan J et al. Active psoriasis and profound CD4+ lymphocytopenia. Br J Dermatol 1997; 136: 930-2.
26. Sitz KV, Keppen M, Johnson DF. Metastatic basal cell carcinoma in acquired immunodeficiency syndrome-related complex. JAMA 1987; 257: 340-3.